Moscow. March 13. INTERFAX.RU – Employees of the Irkutsk Institute of Chemistry were able to synthesize a substance that protects against influenza viruses, including, from H1N1, known as swine flu. This was reported on Tuesday by the press service of the Irkutsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences.
The development of an anti-flu drug was carried out in 2013.
“Working on the modification of carbohydrates, extracted from plant raw materials and synthesized by microorganisms, we received a modified oligosaccharide, which has a pronounced antiviral activity” – quoted the press service of a senior researcher of the pharmaceutical development group of the institute Janu Kostiro.
The substance has successfully passed the research in the Institute of Chemical Biology and Fundamental Medicine of the SB RAS (Novosibirsk) – laboratory mice, which injected it, and then infected with the flu, remained healthy.
At present, Irkutsk chemists establish the structure of matter and develop experimental batches for further research. Novosibirsk biologists will continue to study the antiviral activity and safety of the new compound.
“If the results are positive, it will be possible to conduct preclinical studies.” However, there is still a lot of work to be done to turn the drug into a drug and appear in pharmacies, “the report says.
It is also noted that at the end of 2017, the Irkutsk Institute of Chemistry of the SB RAS received a patent of the Federal Service for Intellectual Property on the method of obtaining a new substance.